Serum magnesium level and arterial calcification in end-stage renal disease

Kidney Int. 1987 Sep;32(3):388-94. doi: 10.1038/ki.1987.222.

Abstract

In this paper we examine the relationship of serum levels of Ca, P, Ca X P, P/Mg, Ca X P/Mg, alkaline phosphatase, and iPTH to the development or regression of peripheral arterial calcifications (AC) in 44 patients with end-stage renal disease being treated by continuous ambulatory peritoneal dialysis (CAPD). The average follow-up time of this longitudinal study was 27 months (range 6-67 months). The patients were divided into two groups: Group A, those showing one or more increases of AC; and Group B, patients in whom AC either did not develop or decreased during the follow-up. There was no significant difference in serum Ca, P, Ca X P, alkaline phosphatase of iPTH between the two groups. However, serum Mg was significantly lower in Group A than in Group B (2.69 +/- 0.52 and 3.02 +/- 0.51 mg/dl, respectively, P less than 0.001), while the ratios P/Mg and Ca X P/Mg were significantly higher. Our observations suggest that in end-stage renal disease hypermagnesemia may retard the development of arterial calcifications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Angiography
  • Arteries
  • Bone Resorption / complications
  • Calcinosis / blood
  • Calcinosis / complications*
  • Calcinosis / diagnostic imaging
  • Calcium / blood
  • Female
  • Humans
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / complications
  • Longitudinal Studies
  • Magnesium / blood*
  • Male
  • Middle Aged
  • Parathyroid Hormone / blood
  • Phosphorus / blood
  • Vascular Diseases / blood
  • Vascular Diseases / complications*
  • Vascular Diseases / diagnostic imaging

Substances

  • Parathyroid Hormone
  • Phosphorus
  • Magnesium
  • Calcium